Bio-Rad Laboratories | Des Atouts





Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
Agilent USD 12.81B 86M 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
General Electric Aerospace USD 130.17B 1.93B 2025-12
Hologic USD 9.18B 165.8M 2025-12
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Merck USD 129.55B 12.02B 2025-09
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
OraSure Technologies USD 423.1M 21.94M 2025-09
Pacific Biosciences Of California USD 803.16M 22.31M 2025-09
Quest Diagnostics USD 16.23B 28M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Siemens EUR 170.13B 3.93B 2025-12
Standard Biotools USD 539.64M 17.32M 2025-09
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Tosoh JPY 1.34T 44.3B 2025-12
Waters USD 5.08B 221.41M 2025-12


Bio-Rad Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.